Percutaneous closure of patent foramen ovale: safe and effective but underutilized.

Nietlispach, Fabian; Meier, Bernhard (2015). Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Expert review of cardiovascular therapy, 13(2), pp. 121-123. Taylor & Francis 10.1586/14779072.2015.1000305

Text 14779072.2015.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (305kB)

With three recently published randomized trials on patent foramen ovale (PFO) closure, the concept of PFO closure to reduce recurrent strokes has been proven; however, PFO closure is currently only considered for secondary prevention. Given the potential devastating consequences of a PFO-related event, we advocate screening for and closure of a PFO for primary prevention in high-risk populations. Such populations include patients who are suffering from a disease that is associated with PFO (e.g., migraine) or patients with high-risk hobbies/professions (e.g., weight-lifters, frequent-flyers, and deep sea divers). Looking at young people with a remaining average life expectancy of 50 years, we have to close 2.4 PFOs to prevent one stroke. This should support a more proactive attitude toward PFO screening and closure.

Interest & Impact

Downloads

1 since deposited on 06 Mar 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item